tykhr
sign in
free sign up
Athenex Inc
Drug Manufacturers-Specialty & Generic
Healthcare
ATNX
7.98 M shares
NASDAQ US
traded
08 May 2023
listed
yes
open
1.45
52 week high
12.20
high
1.45
52 week low
1.32
low
1.29
growth
-56.77 %
previous Close
1.36
P/E ratio
-0
market cap
10.53 M
div yield
0
usd
Dec 2022
qoq
revenue
25.06 M
-25.25 %
net incoming
-28.77 M
-46.27 %
eps
-4.28 %
-52.86 %
eps surprise
-147.40 %
net profit margin
-114.78 %
-56.00 %
operating incoming
-16.72 M
-30.04 %
net change in cash
-4.79 M
-207.73 %
cash on hand
35.62 M
1.23 %
cost of revenue
18.19 M
-34.44 %
top